GSK3, a master switch regulating cell-fate specification and tumorigenesis
- 5 September 2000
- journal article
- review article
- Published by Elsevier in Current Opinion in Genetics & Development
- Vol. 10 (5) , 508-514
- https://doi.org/10.1016/s0959-437x(00)00120-9
Abstract
No abstract availableKeywords
This publication has 65 references indexed in Scilit:
- The pathogenic L392V mutation of presenilin 1 decreases the affinity to glycogen synthase kinase-3βNeuroscience Letters, 2000
- AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1Nature Genetics, 2000
- Control of β-Catenin StabilityMolecular Cell, 2000
- Protein Phosphatase 2Cα Dephosphorylates Axin and Activates LEF-1-dependent TranscriptionPublished by Elsevier ,2000
- Activation of Rat Frizzled-1 Promotes Wnt Signaling and Differentiation of Mouse F9 Teratocarcinoma Cells via Pathways That Require Gαq and Gαo FunctionJournal of Biological Chemistry, 1999
- A GSK3‐binding peptide from FRAT1 selectively inhibits the GSK3‐catalysed phosphorylation of Axin and β‐cateninFEBS Letters, 1999
- Regulation of β-Catenin Signaling by the B56 Subunit of Protein Phosphatase 2AScience, 1999
- The SCFbeta -TRCP-ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in Ikappa Balpha and beta -catenin and stimulates Ikappa Balpha ubiquitination in vitroGenes & Development, 1999
- Axis determination in Xenopus involves biochemical interactions of axin, glycogen synthase kinase 3 and β-cateninCurrent Biology, 1998
- Protein Kinase FA/GSK‐3 Phosphorylates on Ser235‐Pro and Ser404‐Pro that Are Abnormally Phosphorylated in Alzheimer's Disease BrainJournal of Neurochemistry, 1993